Unaudited NAV - Dividend Investment Scheme

Summary by AI BETAClose X

Maven Income and Growth VCT 5 PLC has announced that following the payment of an interim dividend of 0.75p per Ordinary Share, the effective Net Asset Value (NAV) per share will be 28.78p. This NAV will be used to determine the number of new Ordinary Shares issued under the Dividend Investment Scheme for shareholders who elected by August 14, 2026. The company previously reported an unaudited NAV per share of 29.53p as of May 31, 2026.

Disclaimer*

Maven Income and Growth VCT 5 PLC
19 August 2026
 

Maven Income and Growth VCT 5 PLC

 

Unaudited Net Asset Value (NAV) - Dividend Investment Scheme (DIS)

 

On 1 July 2026, the Board of Maven Income and Growth VCT 5 PLC (the Company) announced that the unaudited NAV per Ordinary Share of the Company as at 31 May 2026 was 29.53p and that an interim dividend of 0.75p per Ordinary Share, in respect of the year ended 30 November 2026, would be paid on 28 August 2026, to Shareholders on the register at close of business on 31 July 2026. Furthermore, for Shareholders who had, by no later than 14 August 2026, elected to participate in the DIS, the Company will use the amount paid in respect of the above interim dividend to subscribe for new ordinary shares of 10p each in the Company (Ordinary Shares) to be issued at a price equivalent to the latest announced NAV per share.

 

The Board confirms that, following the payment of this interim dividend, the effective NAV per share of the Company will be 28.78p and that this will be the price used in the calculation of the number of Ordinary Shares to be allotted under the DIS in respect of this interim dividend, the issue of which will be confirmed in a separate announcement in due course.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

19 August 2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings